12- and 18-Month Outcomes and Long- Term Survival of Tofacitinib in Ulcerative Colitis

First published 23/02/2022

Last updated 23/04/2024

EU PAS number:

EUPAS44985

Study

Finalised

Documents

Study protocol

Initial protocol

A3921416 Non Interventional Study Protocol Final 08Feb2022_Redacted

English (1.88 MB - PDF)View document

Updated protocol

A3921416 Non Interventional Study Protocol Amendment 2_clean 06Jun2022_Redacted

First published: 22/02/2024

English (2.52 MB - PDF)View document

Study results

A3921416 NI Study Report 19 November 2022_Redacted

English (3.06 MB - PDF)View document

A3921416 NI Study Report Abstract 19 November 2022_Redacted

English (516.22 KB - PDF)View document

Study report

Other information

Study, other information

A3921416 Non Interventional Study Abstract_Amendment 2_06Jun2022_Redacted

English (1.86 MB - PDF)View document

A3921416 Non Interventional Study Abstract_Final 08Feb2022_Redacted

English (1.7 MB - PDF)View document

ENCePP Seal

ENCePP Seal documents

Secondary tabs